Psilocybin for Amblyopia - Targeting Critical Periods in Humans

Clinical trial registration, sponsored by Johns Hopkins University, registered 5 Nov 2026.

Phase 1/Phase 2 · recruiting · n = 24

Tags: Registry, Psilocybin.

Weekly Science Digest, 30 Oct 2026 to 5 Nov 2026, finding 6: In the clinic

Newly registered at Johns Hopkins: psilocybin alongside amblyopia therapy in adults, testing whether it reopens a visual critical period

How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)

Read the original

—
Node—
Statuslive
Throughput—